Translational biomarker discovery in clinical metabolomics: An introductory tutorial

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1007/s11306-012-0482-9
AuthorSearch for: ; Search for: ; Search for: ; Search for: 1
Affiliation
  1. National Research Council of Canada. National Institute for Nanotechnology
FormatText, Article
Subjectacylcarnitine; amino acid; biological marker; prostate specific antigen; analytic method; analytical parameters; bioinformatics; clinical chemistry; clinical practice; computer program; confidence interval; data processing; diagnostic test; discriminant analysis; gold standard; heart disease; inborn error of metabolism; intermethod comparison; machine learning; malignant neoplastic disease; mathematical computing; metabolite; metabolomics; neurologic disease; newborn screening; partial least squares regression; predictive value; principal component analysis; process development; process model; process optimization; prognosis; protein analysis; protein blood level; protein function; protein processing; protein secretion; receiver operating characteristic; reliability; risk assessment; sample size; screening test; sensitivity and specificity; standard; statistical analysis; validation process
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NPARC number21269877
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier5dcc16ab-ed71-4b75-8adb-a720da50580e
Record created2013-12-13
Record modified2020-04-22
Date modified: